Abstract
Neglected diseases impact over 1 billion people worldwide, causing significant physical, mental, and socioeconomic harm. Current treatments for these diseases often lead to adverse side effects due to pharmacokinetic limitations, which can potentially be addressed. The discovery of safer, more effective drugs can be accelerated and optimized through in silico tools, as well as biological …